Globe Life GL
- Market cap
- $11.9B
- PE
- 10.3×
- 10y median 13.0×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.9×
- Revenue, 12 months
- $6.2B
- +5% on a year ago
- Net margin
- 19.6%
Globe Life trades at 10.3× trailing earnings, cheaper than 75% of the last ten years. Revenue was $6.2B over the last twelve months, up 5% on a year earlier with a 20% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.4B+7% | $1.4B+6% | $1.4B+7% | $1.4B+9% | $1.5B+5% | $1.5B+4% | $1.5B+5% | $1.5B+3% | $1.5B+4% | $1.5B+4% | $1.6B+5% | $1.6B+8% | |
| Interest expense | $26M+8% | $25.7M+4% | $28.6M+15% | $31.4M+22% | $31.4M+21% | $35.7M+39% | $35M+22% | $34.9M+11% | $36.1M+15% | $35.2M−1% | $34M−3% | $36M+3% |
| Pre-tax income | $318.8M+36% | $336.7M+14% | $314.9M+15% | $322.3M+22% | $377M+18% | $312.4M−7% | $316.1M+0% | $313.3M−3% | $477.1M+27% | $329.5M+6% | $334.1M+6% | $354.9M+13% |
| $61.7M+40% | $61.9M+14% | $60.7M+20% | $64M+30% | $74M+20% | $57.2M−8% | $61.5M+1% | $60.5M−5% | $89.3M+21% | $63.4M+11% | $63.6M+3% | $67.1M+11% | |
| Net income | $257.1M+35% | $274.8M+13% | $254.2M+14% | $258.4M+20% | $303M+18% | $255.2M−7% | $254.6M+0% | $252.7M−2% | $387.8M+28% | $266.1M+4% | $270.5M+6% | $287.7M+14% |
| $2.68+38% | $2.88+17% | $2.67+17% | $2.83+26% | $3.44+28% | $3.01+5% | $3.01+13% | $3.05+8% | $4.73+38% | $3.29+9% | $3.39+13% | $3.65+20% | |
| 95.8M−2% | 95.5M−3% | 95.1M−3% | 91.4M−5% | 88.1M−8% | 84.7M−11% | 84.5M−11% | 82.8M−10% | 82M−7% | 80.8M−5% | 79.7M−6% | 78.9M−5% |
EPS, diluted: Q4 FY08 and Q4 FY09: quarter's net income to common over its shares, to the cent, the shares from counts implied by EPS, near the year's EPS less the nine months'. 3 periods, Q4 FY21 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 5 periods, Q2 FY08 to Q1 FY10: not printed by the filing, worked out from its own lines. 16 periods, Q4 FY10 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Insurance - Life nearest Globe Life's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| GLGlobe Life | $11.9B | 10.3× | 13.0× | n/m | 1.9× | +5% | 19.6% |
| UNMUnum | $14.3B | 21.0× | 8.0× | n/m | 1.1× | +3% | 5.3% |
| CRBGCorebridge Financial | $15.2B | 19.8× | 9.8× | n/m | 0.8× | +29% | 4.5% |
| JXNJackson Financial | $8.8B | 183× | 7.6× | n/m | 1.4× | +15% | 1.6% |
| VOYAVoya Financial | $8.7B | 16.2× | 11.9× | n/m | 1.1× | +3% | 7.4% |
| PRIPrimerica | $8.4B | 11.0× | 15.0× | n/m | 2.5× | +9% | 23.2% |
| RGAReinsurance Group of America | $17.2B | 11.6× | 12.5× | n/m | 0.7× | +19% | 5.8% |
| LNCLincoln National | $7.6B | 3.5× | 9.3× | n/m | 0.4× | +8% | 12.2% |
| CNOCNO Financial | $5B | 18.4× | 10.1× | n/m | 1.1× | +6% | 6.0% |
| PRUPrudential Financial | $39.7B | 10.4× | 10.9× | 8.3× | 0.6× | +9% | 6.0% |
| GNWGenworth Financial | $3.4B | 17.1× | 9.4× | n/m | 0.5× | +2% | 2.9% |
| Peer median | $8.7B | 16.6× | 10.0× | 8.3× | 0.9× | +8% | 5.9% |
More on Globe Life
Each number over time
Where it ranks
- #3of 17Life insurers with the highest profit margins
- #4of 16Life insurers with the lowest PE ratio
- #3of 10Life insurers cheapest against their own PE history
- #8of 14Life insurers with the fastest earnings growth
Its groups
About
- Industry
- Insurance - Life
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .